Health Care • Biotechnology: Laboratory Analytical Instruments
$372.18 ▼ -12.22
(-3.18%)
MKT CAP: $9.95B • VOL: 183.1K
52W L $237 52W H $396
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$313
MEDIAN
$417
MEAN
$424
HIGH
$506
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE BIO TAPE
BIO // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $450.34 | $428.01 | 2025-02-14 | $338.68 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $468.95 | $439.17 | 2025-02-06 | $349.85 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $424.29 | $409.40 | 2025-01-29 | $357.29 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $379.62 | — | 2025-01-17 | $364.74 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $327.52 | $353.57 | 2025-01-09 | $331.24 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $442.89 | $387.07 | 2024-12-18 | $323.80 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $361.01 | $375.90 | 2024-12-04 | $346.13 | -4.3% | 48% | C |